INTRODUCTION 16
Research of pluripotent stem cells (PSC), whether embryonic stem (ES) cells or induced 17 pluripotent stem (IPS) cells, has often centered on robustly maintaining pluripotency. Less 18 well investigated is how cells leave the pluripotent stem cell compartment. This is central for 19 a biological understanding of how differentiation is regulated and lineage is specified. Since 20 the use of pluripotent cells in regenerative medicine requires the efficient production of 21 differentiated derivatives, delineating the cellular trajectories by which cells transit from 22 pluripotency into lineage commitment is key. The existence of developmental intermediates 23 on this trajectory may, in part, account for the cellular heterogeneity exhibited by in vitro 24 cultures of human PSC 1 . 25 26 2 Heterogeneity has been described in respect of: (i) "Subsets" of cells with different self 27 renewal potential 2, 3 identified based on surface antigen expression; and (ii) subsets with 28 differential expression of lineage affiliated genes have been described; critically single cell 29 studies have shown these to coexist with stem cell programs 4-6 . Importantly, experimental 30 assays of differentiation have demonstrated that these patterns of gene expression reflect 31 interconvertible substates that functionally encode differential lineage bias within the stem 32 cell compartment 4, 5, 7 . Reporter gene strategies have been particularly useful in this regard. 33
We recently showed, using a fluorescent reporter, that a substate of human PSC expressed 34 the early endoderm related marker GATA6 4 . GATA6 positive cells were able to regenerate 35 long-term pluripotent cultures yet their spontaneous differentiation favored endodermal 36 lineages. That study supports the notion -at least for endoderm-that these substates, which 37 coexpress signatures of pluripotency and differentiation represent differentiation 38 intermediates, may exist normally as transient states. Whether these exist for other lineages 39
is not yet known. It is noteworthy that the pluripotent state of human PSC is itself also 40 transient in development and is in effect "trapped" when human PSC are cultured in vitro. 41
Recently, culture systems that aim to trap cells in an earlier "naïve" stage of development 42 has been reported 8-10 , but whether cells can be trapped further along a particular 43 differentiation trajectory has been less well explored. Cross-antagonism of pro-pluripotency 44 and pro-differentiation signaling in a controlled environment could potentially provide a 45 strategy allowing for the propagation of a pluripotent intermediate with a specific lineage 46 bias. 47
Herein we use a MIXL1 reporter 11 to delineate the cellular trajectory from pluripotency to 48 committed mesoderm progenitors. On this trajectory, we identify within the stem cell 49 compartment a developmental intermediate that also exhibits mesoderm lineage bias. Using 50 a cross antagonism strategy, we can trap and expand this intermediate while retaining its 51 capacity to revert to an unbiased stem cell state. The identification and characterization of 52 mesodermal biased pluripotent intermediates informs our understanding of how mesoderm 53 3 lineage specification occurs and could provide an attractive starting point for directed 54 differentiation towards mesodermal derivatives. 55
56

RESULTS 57
Identification of substates expressing MIXL1-GFP in feeder based culture conditions. 58
Throughout this paper, we have used expression of GFP as a measure of the MIXL1 59 transcriptional state, which we refer to throughout the manuscript as MIXL1. When cultures 60 of the MIXL1 reporter (HES3-MIXL1) were grown on mouse embryo fibroblast (MEF) feeder 61 cells in medium containing Knock-out Serum Replacement (MEF/KOSR condition), they 62 typically contained a subpopulation of 5% to 20% of cells that co-expressed MIXL1 and 63 SSEA-3, a surface antigen that we have previously used as a sensitive marker of 64 undifferentiated stem cells 3, 12, 13 ( Fig. 1a ). 65
To examine the relationship of these MIXL1(+)/SSEA-3(+) cells to the other subpopulations 66 of MIXL1(-)/SSEA-3(+) and MIXL1(+)/SSEA-3(-) cells, putatively stem and differentiated 67 cells, respectively, and to test whether they co-express other markers that are separately 68 indicators of a differentiated or undifferentiated state, we carried out RNA sequencing 69 (RNAseq) analysis of these three subpopulations, isolated by fluorescence-activated cell 70 sorting (FACS). Principle component analysis (PCA) of the entire transcriptomes from these 71
RNAseq data showed a clear separation of the three subpopulations ( Fig. 1b ). In the case of 72 the MIXL1(+)/SSEA-3(+) and MIXL1(-)/SSEA-3(+) cells, data from two biological replicates 73 of each clustered closely, whereas two replicates of the MIXL1(+)/SSEA-3(-) cells were more 74 separated, perhaps reflecting a great heterogeneity and variability expected in populations of 75 differentiated cells. On the other hand, when the PCA was carried out with only a subset of 76 pluripotency associated genes the MIXL1(+)/SSEA-3(+) cluster moved closer to the MIXL1(-77 )/SSEA-3(+) cluster, especially with respect to PC1 which accounts for 89% of variance, 78 whereas when the PCA was carried out with genes associated with mesoderm the 79 4 MIXL1(+)/SSEA-3(+) cluster moved closer to the MIXL1(+)/SSEA-3(-) cluster of putatively 80 differentiated cells ( Fig. 1b ). These analyses suggest that an active pluripotency network 81 might still be in place the MIXL1(+)/SSEA-3(+) cells, consistent with the possibility that they 82 occupy a substate within the stem cell compartment. 83
To test this we analysed each subpopulation for the expression of a signature set of genes 84
( Supplementary Table 1 ), which included 3 controls and 45 genes of interest, by single cell 85 qPCR to assess whether the MIXL1(+)/SSEA-3(+) subpopulation includes individual cells 86 that co-express pluripotency and mesoderm associated genes, and so may represent a 87 transitional substate between that of pristine, pluripotent MIXL1(-)/SSEA-3(+) stem cells and 88 that of mesodermally committed, differentiated MIXL1(+)/SSEA-3(-) cells. The 45 gene set 89 included genes typically associated with the undifferentiated state, such as OCT4, NANOG 90 and SOX2, and genes typically associated with early mesendoderm differentiation, such as 91 T(Brachyury), EOMES and GATA6. Using Monocle2 14 we produced t-distributed stochastic 92 neighbor embedding (t-SNE) analysis of these single cell transcriptomic data. This showed 93 that the MIXL1(+)/SSEA-3(+) cells cluster separately, spanning the space between separate 94 clusters of the MIXL1(-)/SSEA-3(+) and MIXL1(+)/SSEA-3(-) cells, though there was 95 substantial heterogeneity in each cluster ( Fig. 1c ). 96 A more detailed analysis using a subset of the 48 genes that relate most closely to the 97 pluripotent and differentiated states revealed two main clusters of cells, with the MIXL1(-98 )/SSEA-3(+) and MIXL1(+)/SSEA-3(-) displaying an almost complete separation into Cluster 99 A (Pluripotent) and Cluster B (Differentiated), respectively ( Fig. 1d ). By contrast, the 100 MIXL1(+)/SSEA-3(+) subpopulation included cells in both of these clusters, with many cells 101 expressing both pluripotency and differentiation associated genes ( Fig. 1d ). For example, 102 many of the cells in the MIXL1(+)/SSEA-3(+) fraction co-expressed the pluripotency 103 associated marker SOX2 and the mesoderm associated marker T (Fig. 1e ). Similar cells 104
were not often seen in the MIXL1(-)/SSEA-3(+) or MIXL1(+)/SSEA-3(-) fractions. The 105 analysis also highlights the clustering of expression of the pluripotency associated genes, 106 and single cell deposition. From these we were able to grow out 47 colonies. Indexed FACS 117 data confirmed the MIXL1 and SSEA-3 expression levels of the individual cells from which 118 these colonies were obtained ( Fig. 2a ). All of these 47 clonal colonies exhibited a typical 119 rounded human ES cell colony morphology containing cells with a high nuclear to 120 cytoplasmic ratio ( Fig. 2b ). From these, 44 colonies were passaged further, and 27 survived; 121 all were positive for the human PSC cell surface antigen TRA-1-81 ( Supplementary Fig. 2a) . 122
We then randomly selected six clones for further expansion to generate six clonal lines ( Fig.  123 2b). All displayed high levels of expression for a panel of typical human PSC cell surface 124 antigens, BF4, CD9, SSEA-4, TRA-1-60, TRA-1-81 and TRA-2-49 compared to the negative 125 control P3X ( Fig. 2c , Supplmentary Fig. 2c ). Expression of the pluripotency associated 126 marker, NANOG, was confirmed by intracellular staining ( Supplementary Fig. 2b ). Although 127 these clonal lines were all derived from MIXL1(+)/SSEA-3(+) cells ( Fig. 2a ), their pattern of 128 MIXL1 and SSEA-3 expression in each case had reverted to the pattern seen in the parental 129 cultures rather than retaining the MIXL1 positive status of the starting cell ( Fig. 2d ). Thus the 130 The MEF/KOSR system is not fully defined depending on proprietary components and the 138 use of mouse fibroblasts as a feeder layer and the presence of MIXL1(+)/SSEA-3(+) is 139 inherently variable in this system (data not shown) . We tested whether the MIXL1(+)/SSEA-140 3(+) subpopulation existed in completely defined conditions, E8 medium 15 , with a vitronectin 141 attachment factor (E8V) culture conditions. We found that this subpopulation vanished and 142 no MIXL1(+)/SSEA-3(+) cells were detected ( Fig. 3a ). Since we had noted that an inhibitor of 143 endogenous WNT secretion, IWP-2, also inhibited the appearance of MIXL1(+)/SSEA-3(+) 144 cells in MEF/KOSR conditions (data not shown) similar to findings shown before 16 , we 145 inferred that the substate might be regulated by WNT signalling. Therefore, we tested 146 whether activation of WNT signalling in cells cultured in E8V medium could generate this 147 subpopulation. Indeed, the GSK3β inhibitor, CHIR99021 (CHIRON), a canonical WNT 148 signalling mimic, did strongly induce MIXL1 expression but, although initially the MIXL1(+) 149 cells also expressed SSEA-3, within three days (72 Hours) many of the cells were 150 MIXL1(+)/SSEA-3(-) (Fig. 3b ). However, by the further addition of varying levels of 151 lysophophatidic acid (LPA), a promoter of pluripotency (Garcia-Gonzalo et al, 2008, 152 Blaukwamp et al, 2012), we were able to counteract the inductive action of CHIRON and 153 establish conditions in which the pro-and anti-differentiation effects were balanced, so that a 154 substantial proportion of the cells retained expression of both MIXL1 and SSEA-3 ( Fig. 3c ). 155
In these exploratory experiments we had also included ROCK inhibitor (Y-27632); 156 subsequently, we found this is unnecessary and, in the absence of the ROCK inhibitor, we 157 established our initial optimal conditions of 3 µM CHIRON and 0.48 µM LPA to form the 158
Although the combination of CHIRON and LPA was able to generate MIXL1(+)/SSEA-3(+) 160 cells, its ability to maintain this level after passaging was variable. We considered that a 161 possible cause of this variability is the secretion of WNT ligands by cells undergoing early 162 differentiation and that these compromised the level of LPA that we had optimised to 163 counteract the effect of the CHIRON. To address this, we tested a system, similar to the 164 Baseline Activation (BLA) method proposed in Hackland et al, 2017 , in which we added the 165 inhibitor of WNT secretion, IWP-2 17 (Fig. 3d ). When the cells were first grown in the 166 presence of 0.48 µM LPA and 3 µM CHIRON and then passaged in the absence of IWP-2, 167 there was a marked decrease in expression of SSEA-3. However, when the medium also 168 contained 1 µM IWP-2 there was a striking increase in the expression of SSEA-3 after After this initial transcriptomic profiling using PRIMO medium, we found that the formulation 218 required further optimisation to increase the maintenance of cells after multiple passages. 219
We developed a further optimised medium containing a higher level of LPA, termed PRIMO 220
Plus which consisted of E8V basal medium plus 0.2% BSA, 4 µM cholesterol, 3 µM 221 CHIRON, 1 µM IWP-2 and 0.96 µM LPA. From our previous work on MIXL1(+)/SSEA-3(+) 222 cells from feeders we predicted that the same population in PRIMO Plus could again 223 generate clonal stem cell lines but also, as our transcriptomic analysis indicated these cells 224
were on a differentiation trajectory, that their differentiation would be biased towards 225 mesoderm. To confirm this HES3-MIXL1 cells grown for 3 days in PRIMO Plus medium were 226 analysed by cloning and by embryoid body (EB) formation under 'neutral' conditions 18 . The 227 clonal lines established also were used for EB formation. All EBs were then assessed by 228 transcriptome signatures and the score card method 19 (Fig. 5a ). 229
We obtained 38 stem cell-like colonies from 384 MIXL1(+)/SSEA-3(+) cells isolated by FACS 230 and single cell deposition ( Fig. 5b ). Of these, 31 colonies survived further passaging and 231 were positive for TRA-1-81 staining ( Supplementary Fig. 6a ). Six of these colonies were 232 randomly selected, initially expanded in MEF/KOSR conditions ( Supplementary Fig. 6b-c) , 233 transitioned into E8V conditions and then were assessed for their expression of pluripotency 234 associated surface markers expression and MIXL1-GFP (Supplementary 6d-e ); the index 235 position of the parent cells for each of these expanded lines confirmed that they were 236 derived from MIXL1(+)/SSEA-3(+) cells (purple stars in Fig. 5b ). Each of the clones exhibited 237 patterns of antigen expression, and lack of MIXL1-GFP, expression, similar to the parental 238 cells growing in E8V conditions (Fig. 5c ). These cloning results indicate that the 239 10 MIXL1(+)/SSEA-3(+) cells from cultures in PRIMO medium do reside within the stem cell 240 compartment and retain the ability to revert to other stem cell substates. 241
When these Primo-derived clones adapted to growth in E8V were cultured as EBs under 242 neutral conditions they showed marked down-regulation of stem cell related genes and 243 upregulation of genes associated with all three germ layers (Fig. 5d, 5e ), indicating a 244 capacity for multilineage differentiation with no obvious bias. The transcriptional time course 245 analysis of cells in PRIMO showed that both subsets, irrespective of MIXL-GFP expression, 246 are located on the trajectory of mesoderm differentiation induced by CHIRON (Fig. 4d) . 247 Therefore, we tested whether these transcriptional changes would lead to differentiation that 248 favours mesoderm formation. When we collected MIXL1(-)/SSEA-3(+) or MIXL1(+)/SSEA-249
3(+) cells by FACS or unsorted cells grown in PRIMO Plus medium, and grew them as EBs 250
under neutral conditions, they all showed a marked bias to mesoderm differentiation, 251 irrespective of MIXL1 expression. Congruent with the transcriptional time course analysis, 252
EBs showed that cells grown in PRIMO medium are on a mesoderm trajectory which 253 impacts upon their lineage fate decision, an impact that was reversible when clonal lines 254 were established in E8V conditions. 255 256
Multiple passages in PRIMO Plus medium. 257
To confirm that we could maintain human PSC in a biased substate through successive 258 passages, we analysed HES3-MIXL1 ES cells after three passages in PRIMO Plus medium. 259
In addition, we also transitioned into PRIMO Plus medium another human PSC line, H9T-260
Venus, an ES cell line that carries a Venus reporter for T(BRACHYURY) expression 20 , and 261 a human induced pluripotent stem (iPS) cell line, MIFF1 21 , and likewise maintained them 262 through three passages. In each case, the cells retained an undifferentiated morphology and 263 expressed high levels of SSEA3 (Fig. 6a) . The HES3-MIXL1 cultures retained, as before, a 264 population of MIXL1(+)/SSEA-3(+) cells, while the H9T-Venus cultures contained a 265 substantial population of T (Brachyury) (+) cells, this population being more consistently 266 11 abundant than the MIXL1(+) population, whereas in E8V medium there were no MIXL1(+) 267 ( Fig. 3a) or T (Brachyury) (+) cells ( Supplementary Fig. 7a ). These cells also expressed a 268 typical set of pluripotency-associated genes that were down regulated when the cells were 269 allowed to form EBs under neutral differentiation conditions. At the same time, the pattern of 270 induced gene expression indicated a strong mesoderm bias in the differentiation of each of 271 the lines (Fig. 6b) . These results confirm that in the optimised PRIMO Plus medium, human 272 pluripotent stem cells can be maintained following passaging in a mesoderm biased substate 273 within the stem cell compartment. 274 PRIMO Plus remained our optimal medium, but we also tested whether we could substitute 275 components for others that targeted the same or similar pathways. Using H9-T-Venus 276 reporter we found that recombinant Dickkopf WNT Signaling Pathway Inhibitor 1 (DKK1), 277 which inhibits WNT ligand binding to WNT receptors, could be used at 100ng/mL in place of 278 IWP-2 ( Supplementary Fig. 7b ). Similarly, CHIR99021 could be substituted with the GSK3β 279 inhibitor SB216763 at 10µM ( Supplementary Fig. 7c ). For replacement of LPA we focused 280 on activators of G-Coupled Protein receptors. We used various concentrations of 281
Sphingosine-1-phosphate (S1P), another phospholipid present in KOSR medium that has 282 been shown to inhibit differentiation 22, 23 , and a chemical agonist for LPA receptor 2 283 (GRI977143) 24 . The cell expression patterns observed using S1P or GRI977143 media 284 were similar to that observed using LPA-based media, albeit at slightly different 285 concentrations ( Supplementary Fig. 7d-e ). 286
287
We returned to HES3-MIXL1 and our PRIMO Plus formulation to assess further how the long 288 term passaged, mesoderm biased cells related to the trajectory of mesoderm differentiation 289 induced by CHIRON. We also performed bulk RNA-seq analysis on HES3-MIXL1 cells 290 cultured in PRIMO Plus for 10 passages. In addition, to confirm that these cells would revert 291 to the unbiased state apparent in E8V cultures, we also analysed cells that had been 292 cultured in PRIMO Plus for 9 passages and then transitioned back into standard E8V 293 12 medium after one passage in the presence of IWP-2 or LPA to aid reversion. We compared 294 these data (Fig. 6c ) to our previous analysis of the time course of differentiation induced by 295 CHIRON and also cells cultured PRIMO cultures for just 3 days (Fig. 4d ). The transcriptome 296 of both the MIXL1(+)/SSEA3(+) and MIXL1(-)/SSEA3(+) cells after 10 passages in PRIMO 297
Plus correlated with cells located between 18 and 24 hours on the differentiation trajectory, 298 similar to the previously assessed cells after 3 days in PRIMO medium. Crucially, though, 299 when cells were transitioned back into E8V medium these induced transcriptional changes 300 were able to revert to expression levels typical of cells maintained in E8V medium. expression levels across all samples (Fig. 6d) , the protein expression of NANOG and SOX2 307 was also validated by immunofluorescence in PRIMO Plus and reverted cultures 308 ( Supplementary Fig. 8) . One view to accommodate the apparent heterogeneity of hPSC is that the stem cell 315 compartment comprises several interconvertible substates in which the cells retain 316 pluripotency but behave transiently as differentiation intermediates, with distinct propensities 317 for differentiation and lineage selection. We have now identified a mesoderm biased state 318 within human pluripotent stem cell compartment, which we can induce and maintain in 319 13 PRIMO, a defined medium based on cross antagonism, ie simultaneously applying signals 320 that promote differentiation (CHIR99021) and pluripotency (LPA) (Fig. 6e) WNT activation with CHIRON. To counteract this positive feedback loop, we reasoned that 346 we could incorporate a Baseline Activation approach (Hackland et al, 2017) . 347
Baseline Activation as an approach focuses on blocking the endogenous signalling that 348 allows an exact titration of the signal by addition of exogenous agonist, affording tighter 349 control. We used IWP-2 to inhibit WNT ligand secretion, or DKK1 to block WNT ligand 350 binding, while activating the pathway with CHIRON99021 or SB216763. This strategy 351 enabled us to stabilise cultures in PRIMO medium and maintain the cells in this transitory 352 pluripotent state that exhibited mesoderm bias (Fig. 6e) . Importantly, this substate was 353 plastic with cells being able to further differentiate or, when returned to E8 medium, revert to is secreted from the parent myeloma, P3X63Ag8, from which all in house hybridomas had 408 been derived 30 . P3X shows minimal reactivity to human cells (Kohler and Milstein, 1975) . 409
Positive gates were set according to HES3 P3X negative controls. Samples were also 410 stained for P3X to assess non-specific binding. All In order to assess the progress of the clonal line formation we performed live staining for a 427 pluripotency-associated surface marker TRA-1-81. Lines were assessed after the first 428 passage into 48 well plates. TRA-1-81 antibody was added to warm KOSR medium at 1:10 429 dilution and incubated at 37°C for 30 minutes. Wells were then washed twice with KOSR 430 medium before medium containing secondary antibody, Goat anti Mouse Affinipure IgG+IgM 431 (H+L) Alexafluor 647 (Jackson Laboratories) at 1:200 was added to each well, cells were 432 incubated at 37°C for 30 minutes. Wells were then washed once with KOSR medium and 433 twice with FluoroBrite DMEM (ThermoFisher). After imaging the medium was replaced with 434 fresh KOSR medium and returned to 37°C incubator. 435 436 Single Cell Cloning: 437 96 well plates were coated with gelatin and a layer of mouse embryonic feeders. Cells were 438 harvested using Accutase (ThermoFisher). After staining for flow cytometry, DAPI was 439 added at 1:10,000 and used for live/dead discrimination. After gating on the BD Sortware 440 program the desired population was sorted as single cells directly into 96 well plates. The 441 sort was indexed to retain information regarding the MIXL1-GFP and SSEA-3 expression 442 levels. For single cell cloning the medium differed from standard culture. For this we used a 443 50/50 mix between standard KOSR medium and mTESR medium (Stem Cell Technologies) 444 and the addition of 20µM Synthechol (Sigma). During initial plating 10µM Rock Inhibitor, Y-445 27632, was added to the medium. Immediately after sorting into the wells the plates were 446 centrifuged at 1000 rpm for 1 minute to aid attachment of the cells. After two days the 447 medium was replaced with fresh medium to remove the ROCK inhibitor. Colonies were left 448 to develop over 9-12 days before passaging the wells which looked to contained typical 449 hPSC colonies. Colonies were passaged from 96 well plate into a 48 well plate by manual 450 scrapping with a p200 tip, then aspirating and dispensing the dissected colony into one well 451 of a 48 well plate. This 50/50 mix medium was used to grow clones until lines appeared to 452 be growing stably, often up to the third passage before changing into standard KOSR 453 medium. 454 455
Embryoid Bodies 456
To assess the trilineage potential, we used an approached which entailed the formation of 457 Embryoid Bodies (EB) under "neutral" conditions, in this context neutral simply indicates that 458 no exogenous cytokines or chemicals were added to guide differentiation. Cells were either 459 used directly from flasks or after they had been FACS sorted for a particular population. In 460 either situation cells were resuspended in APEL 2 medium (Stem Cell Technologies) 461 containing 10µM ROCKi. Cells were resuspended at 3,000 cells per 50µL. 50µL of cells 462 were added to non-adherent Grenier U bottom 96 well plate. After adding the cells plates 463 were centrifuged at 1000rpm for 3 minutes, to pellet cells. Plates were incubated at 37°C, 464 %CO2 for 7 days. After 7 days EBs were dissolved in Trizol and RNA extracted using the 465 Norgen Total RNA Purification Kit. The RNA was converted to cDNA using the High 466 Capacity cDNA Reverse Transcription Kit (Thermofisher). The samples were then loaded 467 and run on the hPSC scorecards (ThermoFisher), results were analysed by ThermoFisher's 468 scorecard software. Algorithm scores for EBs were normalised to the same cell line growing 469 in E8V conditions. 470 471
Differentiation Time course: 472
Cells growing in E8V medium were supplemented with 3µM CHIRON one day post passage. 473
Cells were collected and stained with anti-SSEA-3 antibody at time points 6, 12, 18, 24, 48, 474 and 72 hours. Cells were sorted directly into Trizol. The medium was refreshed after 48 475 hours with fresh E8V containing 3µM CHIRON. 476 477 478 6.25µL of 2X Reaction Buffer, 1ul of SuperScript III RT/Platinum Taq mix (Invitrogen 505 55549) and 1.5µl of TaqMan assay mix. TaqMan assay mix was prepared by mixing equal 506 volume of all target specific primers ( Supplementary Table 1 ). No-RT controls were prepared 507 with PlatinumTaq Polymerase (Invitrogen, 100021272) and no SuperScript III RT enzyme 508 was included. The PCR conditions were: 60 min at 50C, 2 min at 95C and 25 cycles of 15 509 sec at 95C and 4 min at 60C. Pre-amplified product was diluted 1 to 5 and loaded onto a 510 48.48 chip together with Taqman universal MasterMix (Applied Biosystems 4304437) and 511 the Taqman assays listed in ( Supplementary Table 1 ) with the appropriate loading reagents 512 according to manufacturer's instructions (BioMark 48.48 Dynamic array platform (Fluidigm). 513
Single cell qPCR analysis was performed by two pieces of software. Prior to analysis cells 514 were screened and cells with particularly high CT values (>30) for the housekeeping genes 515 ACTB and RPS18 were removed, across all experiments 9 of 320 single cells were 516 removed. We verified expression of genes with extra wells containing 10 cells rather than 517 single cells, MMP1 was removed from analysis, as it showed no expression in any samples. 518
Depending on the application being used, some pre-processing was performed. 
